Novo Nordisk A/S' Q1 earnings reveal strong growth in semaglutide-driven sales despite a slight revenue miss. Learn more ...

The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.

The FDA will decide whether to approve a once-daily, 25 mg oral formulation of semaglutide (Wegovy) by the end of 2025. If ...

The international study led by a Virginia Commonwealth University researcher found the medication semaglutide, commonly known ...

In today's increasingly competitive market, efficient response and exceptional cost-performance have become crucial for ...

Shortages of pharmaceutical products have been with us for many years. The earliest example of which I am aware dates back to 1942. Currently over 100 products are in shortage, including hormone ...

This contrasts with the currently approved oral GLP-1 RA semaglutide (Rybelsus, Novo Nordisk), a peptide which ideally should be taken fasting and with no food or water for at least 30 minutes ...

AUSTIN (KXAN) — During a press conference on Thursday, Austin Police Chief Lisa Davis recapped a hectic 24 hours involving a home where explosive material was found. “On Tuesday evening a call ...

Conversely, Lilly's stock price jumped about 14.5% to $840. “While Novo had the headstart with approval of semaglutide, we believe that this first mover advantage has waned, with Lilly's ...

Although different active ingredients - Mounjaro is tirzepatide and Ozempic and Wegovy is semaglutide - they all work by mimicking hormones that tell the brain the stomach is full, releasing ...

A US producer of rare earth metals stopped shipments to China after Beijing placed export controls on similar materials crucial for defense and technology manufacturing. MP Materials Corp., which ...

LAS VEGAS, April 17, 2025--(BUSINESS WIRE)--In response to China’s retaliatory tariffs and export controls, MP Materials (NYSE: MP) has ceased shipments of rare earth concentrate to China.